Vaccinate or Get Tested: Federal & State Governments, CDC, Corporations Issue New Directives as Delta Variant Fuels Demand for Recuro COVID At-Home or Onsite Testing Platform

DALLAS–()–Recuro Health (Recuro), an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system, reports sharp, increased employer demand for at-home or on site COVID testing to ensure a safe return-to-work and participation at crucial meetings, events and conventions. Amid the surge of the Delta variant, recurrence of disease even among those who have been vaccinated, a plateau in vaccination rates and directives from all levels of national and local governments to get vaccinated or get tested, a policy for “testing often” is rapidly being adopted across the country as a key to stopping the virus spread.

“With advances in COVID-19 testing, rapid antigen and PCR testing with immediate results are available under the Recuro Health testing solution,” says Michael Gorton, CEO and founder, Recuro Health. “What distinguishes our approach from the myriad of programs on the market is a structured process for test distribution and administration, validation of results and back-end reporting. Furthermore, our solution was one of a dozen chosen from a field of hundreds of companies to collaborate directly with the US Department of Health and Human Services and the FDA during the pandemic.”

An avalanche of requests from employers nationwide for Recuro’s at-home or on-site COVID testing platform follows these announcements:

  • Presidential directive requiring all federal employees to be vaccinated against COVID-19 or submit to regular testing.
  • Centers for Disease Control and Prevention (CDC) revised its COVID-19 test guidance, urging fully vaccinated people to get tested three to five days after exposure to the virus even if they don’t experience symptoms. Prior recommendations indicated fully vaccinated people only needed testing after exposure if they were symptomatic.
  • Health workers at the Department of Veterans Affairs, California state employees and municipal employees in New York City must either provide proof of vaccination, get vaccinated or get regular testing to stop the spread of the highly transmissible Delta variant.

In the U.S., the Delta variant accounts for an estimated 83% of COVID-19 cases and there is a 32% increase in COVID hospitalizations in the last few weeks. Cases are rising in all 50 states but several states have low vaccination rates which are accounting for the Delta variant surge.

Allison Martin, a founder and executive director, Recuro Health, recently participated on a prestigious panel hosted by the National Institutes of Health (NIH) and US Department of Health and Human Services (HHS) at the Association of Chamber of Commerce (ACCE) Summit which focused upon testing solutions. Recuro Health was the only commercial company on the panel.

Listen HERE:

https://www.youtube.com/watch?v=JTHT01f8eXA

“Our real-time test results are available to authorized stakeholders and oversight from nationwide physicians, with unique, customized employer dashboards and tools available to make a reopening strategy easy, simple, safe, customized and compliant,” says Martin.

About Recuro Health

Serving payers, employers and providers, Recuro Health is an integrated digital health solution that delivers value throughout the healthcare ecosystem as care moves from traditional office in-person settings to wherever the patient and data are located. Recuro solutions support the migration from convenient care to meaningful patient engagement across broader care pathways, creating a personalized, holistic digital medical home that results in better outcomes and lower costs. www.recurohealth.com

Leave a comment

Your email address will not be published. Required fields are marked *